Testosterone replacement therapy

被引:9
|
作者
Velazquez, E [1 ]
Arata, GB [1 ]
机构
[1] Univ Los Andes, Sch Med, Dept Med, Endocrinol Unit, Merida, Venezuela
来源
ARCHIVES OF ANDROLOGY | 1998年 / 41卷 / 02期
关键词
male hypogonadism; testosterone replacement;
D O I
10.3109/01485019808987949
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
The benefits conferred by testosterone replacement therapy are substantial, both in the short term for the eradication of symptoms of androgen deficiency, and in the long term for the prevention of osteoporosis. As with any long-term treatment there are risks that must be considered, but overall the benefits achieved far outweigh potential risk. Ideally, androgen replacement therapy should provide physiological serum testosterone levels, as well as DHT and estradiol levels, and correct the clinical symptoms of androgen deficiency in hypogonadal men. This goal is difficult to achieve because the dose dependency of androgen-dependent physiological processes is not known. Androgen preparations that are currently available do not fulfill all criteria for an ideal androgen replacement therapy. Parenteral testosterone esters are effective, safe, practical, and inexpensive. The transdermal testosterone systems provide an alternative to testosterone esters in selected patients but these preparations are expensive. Ongoing studies are showing the benefits of testosterone replacement therapy in aging men, but there is concern about side effects on cardiovascular system and prostate. Thus, clinical decision regarding testosterone therapy in older men should be better defined.
引用
收藏
页码:79 / 90
页数:12
相关论文
共 50 条
  • [1] Testosterone replacement therapy
    Barbonetti, Arcangelo
    D'Andrea, Settimio
    Francavilla, Sandro
    ANDROLOGY, 2020, 8 (06) : 1551 - 1566
  • [2] Testosterone replacement therapy
    Jones, T. H.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2007, 68 (10) : 547 - 553
  • [3] Advances in Testosterone Replacement Therapy
    Gooren, Louis J. G.
    ADVANCES IN THE MANAGEMENT OF TESTOSTERONE DEFICIENCY, 2009, 37 : 32 - 51
  • [4] WHICH TESTOSTERONE REPLACEMENT THERAPY
    CANTRILL, JA
    DEWIS, P
    LARGE, DM
    NEWMAN, M
    ANDERSON, DC
    CLINICAL ENDOCRINOLOGY, 1984, 21 (02) : 97 - 107
  • [5] PERSISTENCE WITH TESTOSTERONE REPLACEMENT THERAPY
    Camper, S. B.
    Puenpatom, R. A.
    Blanchette, C. M.
    Ma, L.
    VALUE IN HEALTH, 2014, 17 (03) : A163 - A163
  • [6] Andropause and testosterone replacement therapy
    de Castro, MPP
    CURRENT KNOWLEDGE IN REPRODUCTIVE MEDICINE, 2000, 1206 : 399 - 407
  • [7] Andrological testosterone replacement therapy
    Paasch, U.
    Glander, H. -J.
    Stolzenburg, J. -U.
    UROLOGE, 2009, 48 (01): : 79 - 86
  • [8] Testosterone replacement therapy - Introduction
    Wu, FCW
    TESTOSTERONE REPLACEMENT THERAPY, 1996, : 1 - 2
  • [9] Pharmacogenetics of testosterone replacement therapy
    Zitzmann, Michael
    PHARMACOGENOMICS, 2009, 10 (08) : 1341 - 1349
  • [10] Testosterone-Replacement Therapy
    Swerdloff, Ronald
    Anawalt, Bradley D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (21): : 2032 - 2034